Off Patent April 2026
Zetia
ezetimibe
Organon LLC a sub of Organon and Co
Tablet (oral) · NDA 021445
Last listed protection ended
April 30, 2026
The FDA listed 1 patent for Zetia, and this is the day the last one ended. It is not the date a generic goes on sale.
Patents and exclusivities
- EndedPatent 7,612,058Claims a use (U-1027, U-1173)
- EndedPatent 7,612,058Pediatric extension: six more months